Mesa Labs Announces Exclusive Distribution Agreement With Tyglar For Critical Validation Products

NEWS FOR IMMEDIATE RELEASE: 09.01.2020 LAKEWOOD, CO – Mesa Laboratories, Inc. (NASDAQ:MLAB) announced it has entered into a strategic distributor agreement with Tyglar.  The two companies intend to collaborate in the market growth and development of critical validation products. The Tyglar-developed MeCo product line enables validation engineers to achieve consistency and robustness between validation cycles…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, July 6, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2020, to shareholders of record at the close of…

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Source: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that the underwriters for its previously announced public offering of common stock have fully exercised their option to purchase 90,000 additional shares of Mesa Labs common stock.…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, January 9, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2020, to shareholders of record at the close of business…

Mesa Labs Reports Record Second Quarter Revenues and Adjusted Operating Income

Lakewood, Colorado, November 6, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record second quarter revenues and adjusted operating income (“AOI”) for the three months ended September 30, 2019. Financial Highlights In comparison to the same quarter in the prior year, second quarter revenues increased 3% to $25.5M,…

Mesa Labs Acquires Gyros Protein Technologies

Lakewood, Colorado, October 31, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and…